BioCatalyst

VCA-894A — catalyst calendar

1 verified catalyst event(s) referencing VCA-894A, each linked to its official source. Verified as of 2026-11-02.

Upcoming

DateEventCompanyDrugOfficial source & verification
2027-03 (month)
in 4mo
ESTIMATED
 READOUT
Treatment of Charcot-Marie-Tooth Disease, Axonal, Type 2S (CMT2S) in an Individu
Phase 1/2 · Charcot Marie Tooth Disease (CMT), Neuromuscular Diseases (NMD)
 VNDA Vanda Pharmaceuticals Inc. VCA-894A ClinicalTrials.gov ↗
✓ Source-checked 2026-11-02
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.